Literature DB >> 6262142

Potency testing of killed polio vaccine in rats.

G van Steenis, A L van Wezel, V M Sekhuis.   

Abstract

Various laboratory animal species were considered for testing the potency of killed poliovaccine. The rat appeared most suitable for obtaining quantitative information by measuring the titre of the antibody response. There was, in general, a good correlation between antibody response in rats and D-antigen titre. This relationship appeared less clear for heat-degraded or long-stored vaccines.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6262142

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN： 0301-5149


  10 in total

1.  A mucosal adjuvant for the inactivated poliovirus vaccine.

Authors:  Benjamin P Steil; Patricia Jorquera; Janny Westdijk; Wilfried A M Bakker; Robert E Johnston; Mario Barro
Journal:  Vaccine       Date:  2013-12-13       Impact factor: 3.641

2.  Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.

Authors:  Koen van der Maaden; Sebastiaan J Trietsch; Heleen Kraan; Eleni Maria Varypataki; Stefan Romeijn; Raphäel Zwier; Heiko J van der Linden; Gideon Kersten; Thomas Hankemeier; Wim Jiskoot; Joke Bouwstra
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

3.  Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.

Authors:  Janny Westdijk; Patrick Koedam; Mario Barro; Benjamin P Steil; Nicolas Collin; Thomas S Vedvick; Wilfried A M Bakker; Peter van der Ley; Gideon Kersten
Journal:  Vaccine       Date:  2013-01-09       Impact factor: 3.641

4.  New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication.

Authors:  Sarah Knowlson; John Burlison; Elaine Giles; Helen Fox; Andrew J Macadam; Philip D Minor
Journal:  PLoS Pathog       Date:  2015-12-31       Impact factor: 6.823

5.  Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines.

Authors:  Helen Fox; Sarah Knowlson; Philip D Minor; Andrew J Macadam
Journal:  PLoS Pathog       Date:  2017-01-19       Impact factor: 6.823

6.  A novel gamma radiation-inactivated sabin-based polio vaccine.

Authors:  Gregory J Tobin; John K Tobin; Elena K Gaidamakova; Taralyn J Wiggins; Ruth V Bushnell; Wai-Ming Lee; Vera Y Matrosova; Stephen J Dollery; Heather N Meeks; Diana Kouiavskaia; Konstantin Chumakov; Michael J Daly
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

7.  Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines.

Authors:  Mohammad W Bahar; Claudine Porta; Helen Fox; Andrew J Macadam; Elizabeth E Fry; David I Stuart
Journal:  NPJ Vaccines       Date:  2021-01-08       Impact factor: 7.344

8.  Development of an animal component free production process for Sabin inactivated polio vaccine.

Authors:  Diego A Suarez-Zuluaga; Leo A van der Pol; Aart G van 't Oever; Wilfried A M Bakker; Yvonne E Thomassen
Journal:  Vaccine X       Date:  2022-09-30

9.  Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals.

Authors:  Yvonne E Thomassen; Aart G van 't Oever; Monique G C T van Oijen; René H Wijffels; Leo A van der Pol; Wilfried A M Bakker
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

10.  Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.

Authors:  Joel R Haynes; Janet Cunningham; Adolph von Seefried; Michael Lennick; Robert T Garvin; Shi-Hsiang Shen
Journal:  Biotechnology (N Y)       Date:  1986
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.